“…After adjustment for multivariate analysis, no clinical factors were correlated with outcomes, except for dyslipidemia, which may suggest that this comorbidity is related both to AS acceleration and its severity, as reported by others 39‐41 . Thus, in our population, factors that have been classically correlated with mortality such as chronic kidney disease and COPD did not maintain significance after adjustments 3,4,30,42,43 . Sinning et al 7 reported that a severe increase in sPAP measured preoperatively was associated with an increased risk of death (hazard ratio [HR], 3.3, p = .003) and a higher incidence of comorbidities such as peripheral vascular arteriopathy, CAD, chronic kidney disease, and atrial fibrillation.…”